Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 392

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

How Can Synergism of Traditional Medicines Benefit from Network Pharmacology?

Yuan, Haidan, Ma, Qianqian, Cui, Heying, Liu, Guancheng, Zhao, Xiaoyan, Li, Wei, Piao, Guangchun·2017·Molecules

Abstract

Abstract: Many prescriptions of traditional medicines (TMs), whose efficacy has been tested in clinical practice, have great therapeutic value and represent an excellent resource for drug discovery. Research into single compounds of TMs, such as artemisinin from Artemisia annua L., has achieved great success; however, it has become evident that a TM prescription (which frequently contains various herbs or other components) has a synergistic effect in effecting a cure or reducing toxicity. Network pharmacology targets biological networks and analyzes the links among drugs, targets, and diseases in those networks. Comprehensive, systematic research into network pharmacology is consistent with the perspective of holisticity, which is a main characteristic of many TMs. By means of network pharmacology, research has demonstrated that many a TM show a synergistic effect by acting at different levels on multiple targets and pathways. This approach effectively bridges the gap between modern medicine and TM, and it greatly facilitates studies into the synergistic actions of TMs. There are different kinds of synergistic effects with TMs, such as synergy among herbs, effective parts, and pure compounds; however, for various reasons, new drug discovery should at present focus on synergy among pure compounds.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules22071135

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 86

  1. Abdullahi, 2011, Trends and challenges of traditional medicine in Africa, Afr. J. Tradit. Complement. Altern. Med., 8, 115, 10.4314/ajtcam.v8i5S.5 · DOI · Paper page
  2. Qi, 2013, Traditional Chinese medicine and related active compounds: A review of their role on hepatitis B virus infection, Drug Discov. Ther., 7, 212, 10.5582/ddt.2013.v7.6.212 · DOI
  3. Mogami, 2014, Beneficial effects of rikkunshito, a Japanese kampo medicine, on gastrointestinal dysfunction and anorexia in combination with Western drug: A systematic review, Evid.-Based Complement. Altern. Med., 2014, 519035, 10.1155/2014/519035 · DOI
  4. Kim, 2014, Recent progress and prospects in Sasang constitutional medicine: A traditional type of physiome-based treatment, Prog. Biophys. Mol. Biol., 116, 76, 10.1016/j.pbiomolbio.2014.09.005 · DOI
  5. Parasuraman, 2014, Polyherbal formation: Concept of ayurveda, Pharmacogn. Rev., 8, 73, 10.4103/0973-7847.134229 · DOI
  6. Oliver, S.J. (2013). The role of traditional medicine practice in primary health care within Aboriginal Australia: A review of the literature. J. Ethnobiol. Ethnomed., 9. · DOI
  7. Zhang, 2013, Advancing drug discovery and development from active constituents of yinchenhao tang, a famous traditional Chinese medicine formula, Evid.-Based Complement. Altern. Med., 2013, 257909, 10.1155/2013/257909 · DOI
  8. Fabricant, 2001, The value of plants used in traditional medicine for drug discovery, Environ. Health Perspect., 109, 69
  9. Ngo, 2013, 21st Century natural product research and drug development and traditional medicines, Nat. Prod. Rep., 30, 584, 10.1039/c3np20120a · DOI
  10. Li, 2011, Progress in the study on the pharmacokinetics of Bicyclol, Med. Res. J., 40, 18
  11. Yuan, H.D., Ma, Q.Q., Ye, L., and Piao, G.C. (2016). The traditional medicine and modern medicine from natural products. Molecules, 21. · DOI
  12. Guo, 2012, Modernization of traditional Chinese medicine, J. Ethnopharmacol., 141, 547, 10.1016/j.jep.2012.05.001 · DOI
  13. Xue, 2013, TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis, Nucleic Acids Res., 41, D1089, 10.1093/nar/gks1100 · DOI
  14. Yang, 2014, Synergy effects of herb extracts: Pharmacokinetics and pharmacodynamic basis, Fitoterapia, 92, 133, 10.1016/j.fitote.2013.10.010 · DOI · Paper page
  15. Kao, 1992, Podophyllotoxin intoxication: Toxic effect of Bajiaolian in herbal therapeutics, Hum. Exp. Toxicol., 11, 480, 10.1177/096032719201100607 · DOI
  16. Ernst, 1998, Harmless herbs? A review of the recent literature, Am. J. Med., 104, 170, 10.1016/S0002-9343(97)00397-5 · DOI
  17. Zhang, 2011, The present situation and development trend of the modernization of Chinese Materia Medica, J. Zhejiang Univ. (Med. Sci.), 40, 349
  18. Xu, 2013, The connotation of modernization of traditional Chinese medicine and some problems, J. New Chin. Med., 45, 160
  19. Zhang, 2008, New research idea for the modernization of TCM experience of combining the medicinal chemistry of natural products with biology in natural products research, Chin. J. Nat. Med., 6, 2, 10.3724/SP.J.1009.2008.00002 · DOI
  20. Xia, 2015, The modernization of traditional Chinese medicine under the background of big data, Asia-Pacific Tradit. Med., 11, 1
  21. Zhang, 2012, Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: Current status and future perspective, J. Ethnopharmacol., 140, 519, 10.1016/j.jep.2012.01.058 · DOI
  22. Shaw, 2012, Pharmacovigilance of herbal medicine, J. Ethnopharmacol., 140, 513, 10.1016/j.jep.2012.01.051 · DOI · Paper page
  23. Liu, 2014, Research progress of network pharmacology, West China J. Pharm. Sci., 29, 723
  24. Pool, 2003, Is it time to move to multidrug combinations?, Am. J. Hypertens., 16, 36, 10.1016/j.amjhyper.2003.07.005 · DOI
  25. Hurwitz, 2008, HIV-1 vaccine development: Tackling virus diversity with a multi-envelope cocktail, Front. Biosci., 13, 609, 10.2741/2706 · DOI
  26. Li, 2012, Qinghaosu (artemisinin): Chemistry and pharmacology, Acta Pharmacol. Sin., 33, 1141, 10.1038/aps.2012.104 · DOI
  27. Zhang, 2011, An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents, Fitoterapia, 82, 1160, 10.1016/j.fitote.2011.07.014 · DOI
  28. Lau, 2012, Synergistic interaction between Astragali Radix and Rehmanniae Radix in a Chinese herbal formula to promote diabetic wound healing, J. Ethnopharmacol., 141, 250, 10.1016/j.jep.2012.02.025 · DOI
  29. Ncube, 2012, In vitro antimicrobial synergism within plant extract combinations from three South African medicinal bulbs, J. Ethnopharmacol., 139, 81, 10.1016/j.jep.2011.10.025 · DOI
  30. Singh, 2015, Synergistic hepatoprotective potential of ethanolic extract of Solanum xanthocarpum and Juniperus communis against paracetamol and azithromycin induced liver injury in rats, J. Tradit. Complement. Med., 6, 370, 10.1016/j.jtcme.2015.07.005 · DOI
  31. Yi, 2009, Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice, Prog. Neuropsychopharmacol. Biol. Psychiatry, 33, 616, 10.1016/j.pnpbp.2009.03.001 · DOI
  32. Li, 2011, In vitro synergistic anti-oxidant activities of solvent-extracted fractions from Astragalus membranaceus and Glycyrrhiza uralensis, LWT—Food Sci. Technol., 44, 1745, 10.1016/j.lwt.2011.02.017 · DOI
  33. Liao, 2010, Correlation between synergistic action of Radix Angelica dahurica extracts on analgesic effects of Corydalis alkaloid and plasma concentration of dl-THP, J. Ethnopharmacol., 129, 115, 10.1016/j.jep.2010.03.005 · DOI
  34. Chicca, 2009, Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts, Int. Immunopharmacol., 9, 850, 10.1016/j.intimp.2009.03.006 · DOI
  35. Uto, 2012, Analysis of the synergistic effect of glycyrrhizin and other constituents in licorice extract on lipopolysaccharide-induced nitric oxide production using knock-out extract, Biochem. Biophys. Res. Commun., 417, 473, 10.1016/j.bbrc.2011.11.143 · DOI
  36. Chen, 2012, Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells, Fitoterapia, 83, 67, 10.1016/j.fitote.2011.09.014 · DOI
  37. Nagaprashantha, 2011, Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer, Biochem. Pharmacol., 82, 1100, 10.1016/j.bcp.2011.07.078 · DOI
  38. Wang, 2008, Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia, Proc. Natl. Acad. Sci. USA, 105, 4826, 10.1073/pnas.0712365105 · DOI · Paper page
  39. Liu, 2014, Application of Proteomics Technique in Study of Network Pharmacology, Prog. Pharm. Sci., 38, 89
  40. Muqbil, I., Bao, G.W., El-Kharraj, R., Shah, M., Mohammad, R.M., Sarkar, F.H., and Azmi, A.S. (2012). Systems and Network Pharmacology Approaches to Cancer Stem Cells Research and Therapy. J. Stem Cell Res. Ther. · DOI
  41. Xiao, 2014, Network pharmacology-based strategy for antitumor drug discovery, J. Int. Pharm. Res., 41, 1
  42. Hopkins, 2007, Network pharmacology, Nat. Biotechnol., 25, 1110, 10.1038/nbt1007-1110 · DOI · Paper page
  43. Peng, 2015, Network pharmacology research technologies and applications, J. Tianjin Univ. TCM, 34, 121
  44. Zhou, 2015, Research progress and development prospect of network pharmacology. Chin, J. Pharmacol. Toxicol., 29, 760
  45. Elgoyhen, 2012, Tinnitus: Network pathophysiology-network pharmacology, Front. Syst. Neurosci., 6, 1, 10.3389/fnsys.2012.00001 · DOI
  46. Azmi, 2010, Proof of concept: Network and systems biology approaches aid in the discovery of potent anticancer drug combinations, Mol. Cancer Ther., 9, 3137, 10.1158/1535-7163.MCT-10-0642 · DOI
  47. Huang, H., Wu, X., Pandey, R., Li, J., Zhao, G., Ibrahim, S., and Chen, J.Y. (2012). C²Maps: A network pharmacology database with comprehensive disease-gene-drug connectivity relationships. BMC Genom., 13. · DOI
  48. An, 2015, Network pharmacology-based antioxidant effect study of Zhi-zi-da-huang decoction for alcoholic liver disease, Evid.-Based Complement. Altern. Med., 2015, 492470, 10.1155/2015/492470 · DOI
  49. Alaimo, 2013, Drug-target interaction prediction through domain-tuned network-based inference, Bioinformatics, 29, 2004, 10.1093/bioinformatics/btt307 · DOI
  50. Yang, 2013, Navigating traditional chinese medicine network pharmacology and computational tools, Evid.-Based Complement. Altern. Med., 2013, 731969, 10.1155/2013/731969 · DOI
  51. Ke, 2015, Study on effective substance basis and molecular mechanism of qi-gui-tong-feng tablet using network pharmacology method, China J. Chin. Mater. Med., 40, 2837
  52. Hu, 2014, VNP: Interactive Visual Network Pharmacology of Diseases, Targets, and Drugs, CPT Pharmacomet. Syst. Pharmacol., 3, e105, 10.1038/psp.2014.1 · DOI
  53. Li, 2012, Traditional Chinese medicine-based network pharmacology could lead to new multicompound drug discovery, Evid.-Based Complement. Altern. Med., 2012, 149762, 10.1155/2012/149762 · DOI
  54. Yildirim, 2007, Drug—Target network, Nat. Biotechnol., 25, 1119, 10.1038/nbt1338 · DOI
  55. Zhao, 2012, Systems pharmacology: Network analysis to identify multiscale mechanisms of drug action, Annu. Rev. Pharmacol. Toxicol., 52, 505, 10.1146/annurev-pharmtox-010611-134520 · DOI
  56. Liu, 2012, Network pharmacology: New opportunity for the modernization of traditional Chinese medicine, Acta Pharm. Sin., 47, 696
  57. Liu, 2014, Network pharmacology study on major active compounds of si-wu decoction analogous formulae for treating primary dysmenorrhea of gynecology blood stasis syndrome, China J. Chin. Mater. Med., 39, 113
  58. Jia, 2015, Prediction of molecular mechanism of Radix Angelicae Pubescentis in treatment of rheumatoid arthritis by network pharmacology, Liaoning J. Tradit. Chin. Med., 42, 1838
  59. Pei, L., Bao, Y., Liu, S., Zheng, J., and Chen, X. (2013). Material basis of Chinese herbal formulas explored by combining pharmacokinetics with network pharmacology. PLoS ONE, 8. · DOI
  60. Wu, 2014, Identifying roles of “Jun-Chen-Zuo-Shi” component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology, Chin. Med., 9, 24, 10.1186/1749-8546-9-24 · DOI
  61. Zhang, 2013, An Integrative platform of TCM network pharmacology and its application on a herbal formula, Qing-Luo-Yin, Evid.-Based Complement. Altern. Med., 2013, 456747
  62. Shi, S.H., Cai, Y.P., Cai, X.J., Zheng, X.Y., Cao, D.S., Ye, F.Q., and Xiang, Z. (2014). A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease. PLoS ONE, 9. · DOI
  63. Li, 2014, A network pharmacology approach to determine active compounds and action mechanisms of ge-gen-qin-lian decoction for treatment of type 2 diabetes, Evid.-Based Complement. Altern. Med., 2014, 495840, 10.1155/2014/495840 · DOI
  64. Xu, H., Zhang, Y., Lei, Y., Gao, X., Zhai, H., Lin, N., Tang, S., Liang, R., Ma, Y., and Li, D. (2014). A systems biology-based approach to uncovering the molecular mechanisms underlying the effects of dragon's blood tablet in colitis, involving the integration of chemical analysis, ADME prediction, and network pharmacology. PLoS ONE, 9. · DOI
  65. Shi, 2014, Network pharmacological studies of huo-xiang-zheng-qi pill in treating functional dyspepsia, Chin. J. New Drugs, 23, 1371
  66. Wang, 2014, Network pharmacology study of mechanism on xue-sai-tong injection against retinal vein occlusion, China J. Chin. Mater. Med., 39, 2322
  67. Pan, 2014, Network pharmacology approach to predict the anti-cancer active ingredients of gan-fu-le against hepatocellular carcinoma, China J. Chin. Mater. Med., 29, 1490
  68. Yu, 2014, Predication of Anti-Diabetes Effects of Corydalis yanhusuo Alkaloids with Pharmacological Network Technology and Experimental Validation in ICR Mice, Chin. Pharm. J., 49, 913
  69. Li, S., Zhang, B., Jiang, D., Wei, Y., and Zhang, N. (2010). Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinform., 11. · DOI
  70. Gu, 2013, CVDHD: A cardiovascular disease herbal database for drug discovery and network pharmacology, J. Cheminform., 5, 51, 10.1186/1758-2946-5-51 · DOI
  71. Zhao, 2015, A network pharmacology based study of regulation effects of the main active components in hong-hua injection on cerebrovascular disease network, Chin. Pharm. J., 50, 1402
  72. Chen, 2015, Structural components of Chinese medicine and pharmacology network: Systematical overall regulation on pathological network, China J. Chin. Mater. Med., 40, 758
  73. Liu, 2014, Research progress of gene expression profiles based on the application of it in traditional Chinese medicine network pharmacology, Lishizhen Med. Mater. Med. Res., 25, 502
  74. Gu, J., Gui, Y., Chen, L., Yuan, G., Lu, H.Z., and Xu, X. (2013). Use of natural products as chemical library for drug discovery and network pharmacology. PLoS ONE, 8. · DOI · Paper page
  75. Hsin, K.Y., Ghosh, S., and Kitano, H. (2013). Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS ONE, 8. · DOI · Paper page
  76. Gu, 2011, Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus, Comput. Biol. Chem., 35, 293, 10.1016/j.compbiolchem.2011.07.003 · DOI
  77. Li, S., Zhang, B., and Zhang, N. (2011). Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst. Biol., 5. · DOI
  78. Zhang, 2013, Network pharmacology: A new approach for Chinese herbal medicine research, Evid.-Based Complement. Altern. Med., 2013, 621423
  79. Zheng, 2011, Pharmacological research on osteoarthritis treated by tou-gu-xiao-tong capsule, J. Fujian Univ. TCM, 21, 43
  80. Hoeng, 2012, A network-based approach to quantifying the impact of biologically active substances, Drug Discov. Today, 17, 413, 10.1016/j.drudis.2011.11.008 · DOI
  81. Zhao, 2014, Bioinformatics approaches in research on network pharmacology of traditional Chinese medicine, Prog. Pharm. Sci., 38, 97
  82. Hopkins, 2008, Network pharmacology: The next paradigm in drug discovery, Nat. Chem. Biol., 4, 682, 10.1038/nchembio.118 · DOI · Paper page
  83. Wang, 2010, Drug targets discovery based on dynamic signal transduction networks, Acta Pharm. Sin., 45, 1
  84. Csermely, 2005, The efficiency of multi-target drugs: The network approach might help drug design, Trends Pharmacol. Sci., 26, 178, 10.1016/j.tips.2005.02.007 · DOI · Paper page
  85. Mayer, 2007, Optimizing combination chemotherapy by controlling drug ratios, Mol. Interv., 7, 216, 10.1124/mi.7.4.8 · DOI
  86. Ihnatova, I., and Budinska, E. (2015). ToPASeq: An R package for topology-based pathway analysis of microarray and RNA-Seq data. BMC Bioinform., 16. · DOI

Metadata

Authors
Yuan, H., Ma, Q., Cui, H., Liu, G., Zhao, X., Li, W., & Piao, G.
Venue
Molecules
Publisher
MDPI AG
Published
2017-07-07
Volume
22
Issue
7
Pages
1135
ISSN
1420-3049
Cited by
392
References
1
Language
en
Funders
National Natural Science Foundation of China (81560698, 81660614)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How Can Synergism of Traditional Medicines Benefit from Network Pharmacology? https://app.cochat.ai/papers/10.3390/molecules22071135
The paper
Yuan, H., Ma, Q., Cui, H., Liu, G., Zhao, X., Li, W., & Piao, G. (2017). How Can Synergism of Traditional Medicines Benefit from Network Pharmacology? Molecules. https://doi.org/10.3390/molecules22071135

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.